Experienced in IgG4-Related Disease

Dr. James E. Hoffman

Hematology Oncology | Hematology | Oncology
University of Miami Health System
University Of Miami
4800 Ne 20th Terrace, 201 Uhealth Cardiology At, 
Fort Lauderdale, FL 
Accepting New Patients
Offers Telehealth

Experienced in IgG4-Related Disease
University of Miami Health System
University Of Miami
4800 Ne 20th Terrace, 201 Uhealth Cardiology At, 
Fort Lauderdale, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Hoffman is a Hematologist Oncology specialist and a Hematologist in Fort Lauderdale, Florida. Dr. Hoffman is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Cardiac Amyloidosis, and Smoldering Multiple Myeloma. Dr. Hoffman is currently accepting new patients.

His clinical research consists of co-authoring 57 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in FL
Languages Spoken
English
Hebrew
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

UNIVERSITY OF MIAMI
4800 Ne 20th Terrace, 201 Uhealth Cardiology At, Fort Lauderdale, FL 33308
Call: 305-243-3440
Other Locations
UNIVERSITY OF MIAMI
1611 Nw 12 Th Ave, Jackson Memorial Hospital, Miami, FL 33136
Call: 305-355-5000
UNIVERSITY OF MIAMI
1475 Nw 12th Ave Courtelis Ctr, C021 Umhc Sccc, Miami, FL 33136
Call: 305-243-6387
UNIVERSITY OF MIAMI
1192 E Newport Ctr Dr, Deerfield Beach, FL 33442

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Drug
Study Drugs: Bortezomib, Carfilzomib, Dexamethasone, Lenalidomide
Study Phase: Phase 3
A Phase 1 Study of SEA-BCMA in Patients With Relapsed or Refractory Multiple Myeloma
A Phase 1 Study of SEA-BCMA in Patients With Relapsed or Refractory Multiple Myeloma
Enrollment Status: Terminated
Publish Date: December 24, 2024
Intervention Type: Drug
Study Drugs: SEA-BCMA, Dexamethasone, Pomalidomide
Study Phase: Phase 1
Screening to Improve Survival in AL Amyloidosis
Screening to Improve Survival in AL Amyloidosis
Enrollment Status: Completed
Publish Date: October 28, 2024
A Phase 1a/1b Multicenter, Single-Arm, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Preliminary Activity of Oral ACY-241 Alone and in Combination With Pomalidomide and Low-Dose Dexamethasone in Patients With Relapsed or Relapsed-and-Refractory Multiple Myeloma
A Phase 1a/1b Multicenter, Single-Arm, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Preliminary Activity of Oral ACY-241 Alone and in Combination With Pomalidomide and Low-Dose Dexamethasone in Patients With Relapsed or Relapsed-and-Refractory Multiple Myeloma
Enrollment Status: Terminated
Publish Date: July 09, 2024
Intervention Type: Drug
Study Drugs: ACY-241, Pomalidomide, Dexamethasone
Study Phase: Phase 1
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care Versus Placebo Plus Standard of Care in Subjects With Light Chain (AL) Amyloidosis
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care Versus Placebo Plus Standard of Care in Subjects With Light Chain (AL) Amyloidosis
Enrollment Status: Terminated
Publish Date: November 14, 2023
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 2b, Open-Label, Single-Arm Study of Selinexor (KPT-330) Plus Low-Dose Dexamethasone (Sd) in Patients With Multiple Myeloma Previously Treated With Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib, and an Anti-CD38 Monoclonal Antibody (mAb) Daratumumab, and Refractory to Prior Treatment With Glucocorticoids, an Immunomodulatory Agent, a Proteasome Inhibitor, and an the Anti-CD38 mAb Daratumumab
A Phase 2b, Open-Label, Single-Arm Study of Selinexor (KPT-330) Plus Low-Dose Dexamethasone (Sd) in Patients With Multiple Myeloma Previously Treated With Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib, and an Anti-CD38 Monoclonal Antibody (mAb) Daratumumab, and Refractory to Prior Treatment With Glucocorticoids, an Immunomodulatory Agent, a Proteasome Inhibitor, and an the Anti-CD38 mAb Daratumumab
Enrollment Status: Completed
Publish Date: January 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
Open-Label Pilot Study to Assess the Safety, Tolerability and Antitumor Activity of Genetically Engineered NY-ESO-1 Specific (c259) T Cells Alone or in Combination With Pembrolizumab in HLA-A2+ Subjects With NY-ESO-1 and/or LAGE-1a Positive Relapsed and Refractory Multiple Myeloma
Open-Label Pilot Study to Assess the Safety, Tolerability and Antitumor Activity of Genetically Engineered NY-ESO-1 Specific (c259) T Cells Alone or in Combination With Pembrolizumab in HLA-A2+ Subjects With NY-ESO-1 and/or LAGE-1a Positive Relapsed and Refractory Multiple Myeloma
Enrollment Status: Terminated
Publish Date: January 11, 2022
Intervention Type: Drug
Study Drugs: Letetresgene Autoleucel, Letetresgene Autoleucel with Pembrolizumab, Fludarabine, Cyclophosphamide, Pembrolizumab
Study Phase: Phase 1
Collection of Peripheral Blood Samples From Patients With Carpal Tunnel Syndrome for Laboratory Screening of Amyloidosis
Collection of Peripheral Blood Samples From Patients With Carpal Tunnel Syndrome for Laboratory Screening of Amyloidosis
Enrollment Status: Completed
Publish Date: August 26, 2021
View 7 Less Clinical Trials

57 Total Publications

A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy.
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy.
Journal: Future cardiology
Published: December 12, 2025
View All 57 Publications
Similar Doctors
Experienced in IgG4-Related Disease
Dr. Frances A. Behrmann
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Frances A. Behrmann
Hematology Oncology | Hematology | Oncology

Baptist Health Medical Group Oncology LLC

8900 N Kendall Dr, 
Miami, FL 
 (37.5 miles away)
786-596-1960
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Frances Behrmann is a Hematologist Oncology specialist and a Hematologist in Miami, Florida. Dr. Behrmann is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Behrmann is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Karim A. Arnaout
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Karim A. Arnaout
Hematology Oncology | Hematology | Oncology

Holy Cross Hospital Inc

4725 N Federal Hwy Cancer Ctr, Holy Cross Medical Group, 
Ft Lauderdale, FL 
 (0.1 miles away)
954-267-7700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Karim Arnaout is a Hematologist Oncology specialist and a Hematologist in Ft Lauderdale, Florida. Dr. Arnaout is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, Bone Marrow Aspiration, and Ureteroscopy. Dr. Arnaout is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Liat N. Dagan
Oncology | Hematology | Hematology Oncology
Experienced in IgG4-Related Disease
Dr. Liat N. Dagan
Oncology | Hematology | Hematology Oncology

Brrh Oncology, LLC

800 Meadows Rd, 
Boca Raton, FL 
 (11.9 miles away)
561-955-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Liat Dagan is an Oncologist and a Hematologist in Boca Raton, Florida. Dr. Dagan is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Anemia, Chronic Lymphocytic Leukemia (CLL), Thrombocytopenia, and Chronic B-Cell Leukemia (CBCL). Dr. Dagan is currently accepting new patients.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hoffman's expertise for a condition
ConditionClose
  • Elite
  • Multiple Myeloma
    Dr. Hoffman is
    Elite
    . Learn about Multiple Myeloma.
    See more Multiple Myeloma experts
  • Primary Amyloidosis
    Dr. Hoffman is
    Elite
    . Learn about Primary Amyloidosis.
    See more Primary Amyloidosis experts
  • Distinguished
  • Cardiac Amyloidosis
    Dr. Hoffman is
    Distinguished
    . Learn about Cardiac Amyloidosis.
    See more Cardiac Amyloidosis experts
  • Cerebral Amyloid Angiopathy
    Dr. Hoffman is
    Distinguished
    . Learn about Cerebral Amyloid Angiopathy.
    See more Cerebral Amyloid Angiopathy experts
  • Hereditary Cerebral Amyloid Angiopathy
    Dr. Hoffman is
    Distinguished
    . Learn about Hereditary Cerebral Amyloid Angiopathy.
    See more Hereditary Cerebral Amyloid Angiopathy experts
  • Light Chain Deposition Disease (LCDD)
    Dr. Hoffman is
    Distinguished
    . Learn about Light Chain Deposition Disease (LCDD).
    See more Light Chain Deposition Disease (LCDD) experts
  • MAGIC Syndrome
    Dr. Hoffman is
    Distinguished
    . Learn about MAGIC Syndrome.
    See more MAGIC Syndrome experts
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    Dr. Hoffman is
    Distinguished
    . Learn about Monoclonal Gammopathy of Undetermined Significance (MGUS).
    See more Monoclonal Gammopathy of Undetermined Significance (MGUS) experts
View All 13 Distinguished Conditions
  • Advanced
  • Classical Hodgkin Lymphoma
    Dr. Hoffman is
    Advanced
    . Learn about Classical Hodgkin Lymphoma.
    See more Classical Hodgkin Lymphoma experts
  • Cyclic Neutropenia
    Dr. Hoffman is
    Advanced
    . Learn about Cyclic Neutropenia.
    See more Cyclic Neutropenia experts
  • Diffuse Large B-Cell Lymphoma (DLBCL)
    Dr. Hoffman is
    Advanced
    . Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
    See more Diffuse Large B-Cell Lymphoma (DLBCL) experts
  • Familial Transthyretin Amyloidosis
    Dr. Hoffman is
    Advanced
    . Learn about Familial Transthyretin Amyloidosis.
    See more Familial Transthyretin Amyloidosis experts
  • Hodgkin Lymphoma
    Dr. Hoffman is
    Advanced
    . Learn about Hodgkin Lymphoma.
    See more Hodgkin Lymphoma experts
  • Large-Cell Immunoblastic Lymphoma
    Dr. Hoffman is
    Advanced
    . Learn about Large-Cell Immunoblastic Lymphoma.
    See more Large-Cell Immunoblastic Lymphoma experts
View All 8 Advanced Conditions
  • Experienced
  • Acute Lymphoblastic Leukemia (ALL)
    Dr. Hoffman is
    Experienced
    . Learn about Acute Lymphoblastic Leukemia (ALL).
    See more Acute Lymphoblastic Leukemia (ALL) experts
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Hoffman is
    Experienced
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Hoffman is
    Experienced
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • Acute Myeloid Leukemia (AML)
    Dr. Hoffman is
    Experienced
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Adult T-Cell Leukemia
    Dr. Hoffman is
    Experienced
    . Learn about Adult T-Cell Leukemia.
    See more Adult T-Cell Leukemia experts
  • Agranulocytosis
    Dr. Hoffman is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
View All 45 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved